Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Genetic Regulation of Guanylate-Binding Proteins 2b and 5 during Leishmaniasis in Mice

Y. Sohrabi, V. Volkova, T. Kobets, H. Havelková, I. Krayem, M. Slapničková, P. Demant, M. Lipoldová,

. 2018 ; 9 (-) : 130. [pub] 20180207

Language English Country Switzerland

Document type Journal Article

Interferon-induced GTPases [guanylate-binding proteins (GBPs)] play an important role in inflammasome activation and mediate innate resistance to many intracellular pathogens, but little is known about their role in leishmaniasis. We therefore studied expression ofGbp2b/Gbp1andGbp5mRNA in skin, inguinal lymph nodes, spleen, and liver afterLeishmania majorinfection and in uninfected controls. We used two different groups of related mouse strains: BALB/c, STS, and CcS-5, CcS-16, and CcS-20 that carry different combinations of BALB/c and STS genomes, and strains O20, C57BL/10 (B10) and B10.O20, OcB-9, and OcB-43 carrying different combinations of O20 and B10 genomes. The strains were classified on the basis of size and number of infection-induced skin lesions as highly susceptible (BALB/c, CcS-16), susceptible (B10.O20), intermediate (CcS-20), and resistant (STS, O20, B10, OcB-9, OcB-43). Some uninfected strains differed in expression ofGbp2b/Gbp1andGbp5, especially ofGbp2b/Gbp1in skin. Uninfected BALB/c and STS did not differ in their expression, but in CcS-5, CcS-16, and CcS-20, which all carry BALB/c-derivedGbpgene-cluster, expression ofGbp2b/Gbp1exceeds that of both parents. These data indicatetrans-regulation ofGbps. Infection resulted in approximately 10× upregulation ofGbp2b/Gbp1andGbp5mRNAs in organs of both susceptible and resistant strains, which was most pronounced in skin. CcS-20 expressed higher level ofGbp2b/Gbp1than both parental strains in skin, whereas CcS-16 expressed higher level ofGbp2b/Gbp1than both parental strains in skin and liver. This indicates atrans-regulation present in infected mice CcS-16 and CcS-20. Immunostaining of skin of five strains revealed in resistant and intermediate strains STS, CcS-5, O20, and CcS-20 tight co-localization of Gbp2b/Gbp1 protein with mostL. majorparasites, whereas in the highly susceptible strain, BALB/c most parasites did not associate with Gbp2b/Gbp1. In conclusion, expression ofGbp2b/Gbp1andGbp5was increased even in organs of clinically asymptomatic resistant mice. It suggests a hidden inflammation, which might contribute to control of persisting parasites. This is supported by the co-localization of Gbpb2/Gbp1 protein andL. majorparasites in skin of resistant and intermediate but not highly susceptible mice.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18009987
003      
CZ-PrNML
005      
20180404165937.0
007      
ta
008      
180404s2018 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2018.00130 $2 doi
035    __
$a (PubMed)29467757
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Sohrabi, Yahya $u Laboratory of Molecular and Cellular Immunology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
245    10
$a Genetic Regulation of Guanylate-Binding Proteins 2b and 5 during Leishmaniasis in Mice / $c Y. Sohrabi, V. Volkova, T. Kobets, H. Havelková, I. Krayem, M. Slapničková, P. Demant, M. Lipoldová,
520    9_
$a Interferon-induced GTPases [guanylate-binding proteins (GBPs)] play an important role in inflammasome activation and mediate innate resistance to many intracellular pathogens, but little is known about their role in leishmaniasis. We therefore studied expression ofGbp2b/Gbp1andGbp5mRNA in skin, inguinal lymph nodes, spleen, and liver afterLeishmania majorinfection and in uninfected controls. We used two different groups of related mouse strains: BALB/c, STS, and CcS-5, CcS-16, and CcS-20 that carry different combinations of BALB/c and STS genomes, and strains O20, C57BL/10 (B10) and B10.O20, OcB-9, and OcB-43 carrying different combinations of O20 and B10 genomes. The strains were classified on the basis of size and number of infection-induced skin lesions as highly susceptible (BALB/c, CcS-16), susceptible (B10.O20), intermediate (CcS-20), and resistant (STS, O20, B10, OcB-9, OcB-43). Some uninfected strains differed in expression ofGbp2b/Gbp1andGbp5, especially ofGbp2b/Gbp1in skin. Uninfected BALB/c and STS did not differ in their expression, but in CcS-5, CcS-16, and CcS-20, which all carry BALB/c-derivedGbpgene-cluster, expression ofGbp2b/Gbp1exceeds that of both parents. These data indicatetrans-regulation ofGbps. Infection resulted in approximately 10× upregulation ofGbp2b/Gbp1andGbp5mRNAs in organs of both susceptible and resistant strains, which was most pronounced in skin. CcS-20 expressed higher level ofGbp2b/Gbp1than both parental strains in skin, whereas CcS-16 expressed higher level ofGbp2b/Gbp1than both parental strains in skin and liver. This indicates atrans-regulation present in infected mice CcS-16 and CcS-20. Immunostaining of skin of five strains revealed in resistant and intermediate strains STS, CcS-5, O20, and CcS-20 tight co-localization of Gbp2b/Gbp1 protein with mostL. majorparasites, whereas in the highly susceptible strain, BALB/c most parasites did not associate with Gbp2b/Gbp1. In conclusion, expression ofGbp2b/Gbp1andGbp5was increased even in organs of clinically asymptomatic resistant mice. It suggests a hidden inflammation, which might contribute to control of persisting parasites. This is supported by the co-localization of Gbpb2/Gbp1 protein andL. majorparasites in skin of resistant and intermediate but not highly susceptible mice.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Volkova, Valeryia $u Laboratory of Molecular and Cellular Immunology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
700    1_
$a Kobets, Tatyana $u Laboratory of Molecular and Cellular Immunology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
700    1_
$a Havelková, Helena $u Laboratory of Molecular and Cellular Immunology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
700    1_
$a Krayem, Imtissal $u Laboratory of Molecular and Cellular Immunology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
700    1_
$a Slapničková, Martina $u Laboratory of Molecular and Cellular Immunology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
700    1_
$a Demant, Peter $u Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, NY, United States.
700    1_
$a Lipoldová, Marie $u Laboratory of Molecular and Cellular Immunology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 9, č. - (2018), s. 130
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29467757 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180404170017 $b ABA008
999    __
$a ind $b bmc $g 1287472 $s 1006799
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 9 $c - $d 130 $e 20180207 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...